<?xml version="1.0" ?>
<doc>
	<str name="Patent Number">
		US7396467
	</str>
	<str name="Application Number">
		US10964269
	</str>
	<str name="Kind Code">
		B2
	</str>
	<str name="Title">
		Method of preparing a chromatography matrix
	</str>
	<str name="Abstract">
		The present invention relates to a method of preparing a porous cross-linked polysaccharide chromatography matrix, which comprises to provide an aqueous solution of a gellable polysaccharide, wherein part of the hydroxyl groups are substituted with groups which are not susceptible to nucleophilic attack; to provide essentially spherical droplets of the substituted polysaccharide solution; to form a gel of the substituted polysaccharide solution; and to cross-link the gel by adding a cross-linking agent. The invention also encompasses a chromatography column packed with a matrix so produced as well as use thereof in e.g. protein purification.
	</str>
	<str name="Document Types">
		US | USB | DOCDB
	</str>
	<str name="Application Date">
		2004-10-13
	</str>
	<str name="Application Year">
		2004
	</str>
	<str name="Application(Year/Month)">
		2004-10
	</str>
	<str name="Publication Date">
		2008-07-08
	</str>
	<str name="Publication Year">
		2008
	</str>
	<str name="Publication(Year/Month)">
		2008-07
	</str>
	<str name="All IPC">
		B01D15/08
	</str>
	<str name="IPC Primary">
		B01D15/08
	</str>
	<str name="IPC Section">
		B
	</str>
	<str name="IPC Class">
		B01
	</str>
	<str name="IPC Subclass">
		B01D
	</str>
	<str name="IPC Group">
		B01D15
	</str>
	<str name="All UPC">
		210/198.2 | 210/635 | 210/656 | 210/502.1
	</str>
	<str name="UPC Primary">
		210/198.2
	</str>
	<str name="UPC Class">
		210
	</str>
	<str name="Family Members">
		US20060060534A1 | US7396467 | CN100537022C | CN101031356A | SE0402322D0
	</str>
	<str name="Family Member Count">
		5
	</str>
	<str name="Family Members Cited By Count">
		1
	</str>
	<str name="Other References">
		Gel Filtration--Principles and Methods; Handbook from Pharmacia LKB Biotechnology, 5th Edition, 1991, pp. 41-42. cited by other.
	</str>
	<str name="Other References Count">
		1
	</str>
	<str name="Cited By">
		US8298657
	</str>
	<str name="Cited By Count">
		1
	</str>
	<str name="Cites">
		US3956273 | US6689715 | US6602990 | US5135650 | US4973683 | US6635174 | US5998606 | US5728457 | US5541255 | US5143646
	</str>
	<str name="Cites Count">
		10
	</str>
	<str name="Priority Country">
		SE
	</str>
	<str name="Priority Number">
		0402322
	</str>
	<str name="Priority Date">
		2004-09-22
	</str>
	<str name="Assignee(s)">
		GE HEALTHCARE BIO-SCIENCES AB
	</str>
	<str name="1st Assignee">
		GE HEALTHCARE BIO-SCIENCES AB
	</str>
	<str name="Number of Assignees">
		1
	</str>
	<str name="1st Assignee Address">
		Uppsala, SE
	</str>
	<str name="Assignee(s) Address">
		Uppsala, SE
	</str>
	<str name="Inventor(s)">
		BERG, HANS | BUCKLEY, DAVID | BRANNHOLM, MARIA | HAGVALL, ANDERS | IHRE, HENRIK | HOLMGREN, EVA | LARSSON, ANDERS | LINDSTROM, DAG
	</str>
	<str name="1st Inventor">
		BERG, HANS
	</str>
	<str name="Number of Inventors">
		8
	</str>
	<str name="1st Inventor Address">
		Uppsala, SE
	</str>
	<str name="Inventor(s) Address">
		Uppsala, SE | Uppsala, SE | Uppsala, SE | Uppsala, SE | Sundbyberg, SE | Uppsala, SE | Bromma, SE | Vattholma, SE
	</str>
	<str name="Agent/Attorney">
		JI, YONGGANG
	</str>
	<str name="Primary Examiner">
		THERKORN, ERNEST G
	</str>
	<str name="cited by within 3 years">
		1
	</str>
	<str name="cited by within 5 years">
		1
	</str>
</doc>

